WASHINGTON – After some initial success containing drug prices, private insurers in the new Medicare prescription drug program may be losing their leverage over drug manufacturers as they try to hold down medicine costs for seniors and the federal government, House investigators have found. Prices… Read More
Comments for: Efforts to keep drug costs in check starting to falter
Efforts to keep drug costs in check starting to falter
You may also like
Efforts to keep drug costs in check starting to falter